Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia. | Am J Nephrol;55(2): 255-259, 2024. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia.

Packer, Milton.

Affiliation

Packer M; Baylor Heart and Vascular Institute, Dallas, Texas, USA.

Am J Nephrol ; 55(2): 255-259, 2024.

Article in En | MEDLINE | ID: mdl-37231827

Subject(s)
Key words

Erythropoietin; HIF-inhibitor; SGLT2 inhibitors

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Insufficiency, Chronic / Prolyl-Hydroxylase Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Hematinics / Anemia Limits: Humans Language: En Journal: Am J Nephrol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Erythropoietin / Renal Insufficiency, Chronic / Prolyl-Hydroxylase Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Hematinics / Anemia Limits: Humans Language: En Journal: Am J Nephrol Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza